GRIN2A and Stroke: Interestingly, detection of NMDA-R NR2A antibodies and NR2 concentrations might have a temporal profile after ischemic stroke (with a peak after 12 h) (48, 98) that might contribute to pinpointing a patients stage of stroke evolution but these results need to be validated in specifically designed studies.